2015 APHA Annual Meeting & Expo

Home Events & Meetings Annual Meeting Schedule & Program

Recorded Annual Meeting Presentations (RAMP) are now available for purchase.
Only $90 for presenters, $140 for registered attendees and $200 for non-attendees.

Online Program

322326
Outcome and impact evaluations


Sunday, November 1, 2015 : 9:00 a.m. - 9:30 a.m.

Michael D. Kogan, PhD, Office of Epidemiology and Research, HRSA / Maternal and Child Health Bureau, Rockville, MD
This part of the workshop will cover summative evaluations, which will encompass outcome evaluations and impact evaluations. In many ways, this is the heart of the course.  We will first discuss the purpose of outcome evaluations, which is to investigate to what extent the program is achieving its outcomes. We will cover both the short-term and medium-term changes in program participants that could result directly from the program, such as improvements in knowledge, attitudes, or behaviors. We will then turn to impact evaluations, which focus on broader, longer-term changes that have occurred as a result of the program. These impacts could be the health impacts on a community or state.

Learning Areas:

Conduct evaluation related to programs, research, and other areas of practice

Learning Objectives:
Discuss various methods of summative evaluations.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: Michael Kogan, PhD is the Director of the Office of Epidemiology and Research at the Maternal and Child Health (MCH) Bureau, which is also responsible for program evaluations. He has initiated courses on program evaluation, given talks on strengthening the scientific rigor of public health programs, and conducted numerous workshops on performance measurement, evidence-based public health, and scientific writing. He chaired the workgroup which developed a new performance measurement system for MCH in the US.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 2011.0: How to evaluate public health programs--Fee: $275